Hippel Lindau Disease
Mostrando 1-12 de 53 artigos, teses e dissertações.
-
1. Imaging manifestations of von Hippel-Lindau disease: an illustrated guide focusing on abdominal manifestations
Resumo A doença de von Hippel-Lindau (VHL) é uma desordem autossômica dominante monogênica com mutações na linha germinativa do antioncogene VHL, no braço curto do cromossomo três (3p25-26). Afeta 1:36.000-50.000 indivíduos, com penetrância superior a 90% aos 65 anos de idade. Embora tenha início e apresentação variáveis, com pleiotropismo mesm
Radiologia Brasileira. Publicado em: 2022
-
2. Metastatic renal cell carcinoma management
PURPOSE: To assess the current treatment of metastatic renal cell carcinoma, focusing on medical treatment options. MATERIAL AND METHODS: The most important recent publications have been selected after a literature search employing PubMed using the search terms: advanced and metastatic renal cell carcinoma, anti-angiogenesis drugs and systemic therapy; also
International braz j urol. Publicado em: 2009-06
-
3. Identificação e caracterização de mutações germinativas no gene VHL em famílias com a doença de von Hippel-Lindau / Identification and characterization of germline mutations in the VHL gene in families with von Hippel-Lindau disease
A doença de von Hippel-Lindau (VHL) é uma síndrome de câncer familial herdada de forma autossômica dominante que predispõe ao desenvolvimento de diversos tipos de neoplasias benignas e malignas. É causada por mutações germinativas e somáticas no gene VHL e tem uma incidência aproximada de um a cada 36.000 nascimentos. O gene VHL é um supressor tu
Publicado em: 2008
-
4. Preimplantation genetic diagnosis of Von Hippel-Lindau disease cancer syndrome by combined mutation and segregation analysis
Von Hippel-Lindau (VHL) disease is an autosomal dominant cancer syndrome, associated with the development of tumors and cysts in multiple organ systems, whose expression and age of onset are highly variable. The VHL disease tumor suppressor gene (VHL) maps to 3p25-p26 and mutations ranging from a single base change to large deletions have been detected in pa
Genetics and Molecular Biology. Publicado em: 2007-03
-
5. Mutation screening in the VHL, SDHB and SDHD genes in patients with sporadic pheochromocytoma and/or paraganglioma / Rastreamento de mutações nos genes VHL, SDHB e SDHD em pacientes portadores de feocromocitoma ou também, paraganglioma esporádico
Pheochromocytomas are neuroendocrine tumors composed of chromaffin cells that produce and secrete catecholamines as well as a variety of neuropeptides, whose most common clinical manifestation is arterial hypertension. Twelve to 24% of the apparently sporadic pheochromocytomas, present germline mutations in genes previously associated to inherited familiar s
Publicado em: 2007
-
6. Histological differentiation of metastatic renal carcinoma in the cerebellum from cerebellar haemangioblastoma in von Hippel-Lindau's disease.
Two cases of von Hippel-Lindau's disease with special reference to the occurrence of renal carcinoma are presented. The first case demonstrates the difficulty of differentiating cerebellar haemangioblastoma from metastatic renal carcinoma affecting the cerebellum. The valuable differentiating histological features were positive staining of metastatic renal c
-
7. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
A family with von Hippel-Lindau disease (VHL) type 2A has been shown to have a T to C missense mutation at nucleotide 547 of the VHL gene. This gives further support for the proposal to associate the 547 T to C mutation with phenotype VHL 2A.
-
8. Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease.
Glandular tumours involving the middle ear and the mastoid are rare, and distinguishing between adenoma and adenocarcinoma is difficult. Two distinct histopathological patterns are accepted. While their clinical presentation differs, both require primary surgical treatment and both have a high rate of local recurrence. The papillary form takes a more aggress
-
9. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
The von Hippel-Lindau tumor suppressor gene (VHL) has a critical role in the pathogenesis of clear-cell renal cell carcinoma (RCC), as VHL mutations have been found in both von Hippel-Lindau disease-associated and sporadic RCCs. Recent studies suggest that vascular endothelial growth factor (VEGF) mRNA is upregulated in RCC- and von Hippel-Lindau disease-ass
-
10. Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Background: Head and neck paragangliomas (HNPs) occur as sporadic or familial entities, the latter mostly in association with germline mutations of the SDHB, SDHC, or SDHD (SDHx) genes. Heritable non-SDHx HNP might occur in von Hippel-Lindau disease (VHL, VHL gene), multiple endocrine neoplasia type 2 (MEN2, RET gene), and neurofibromatosis type 1 (NF1, NF1
The Endocrine Society.
-
11. Von Hippel-Lindau disease.
-
12. Pancreatic involvement in Hippel-Lindau disease.